Physician

Akash Patnaik

According to 2025 Medicare claims, Akash Patnaik (NPI: 1750360962) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is THE UNIVERSITY OF CHICAGO MEDICAL CENTER (NPI: 1033218128; TIN: 36-3488183) and primary practice location at 60637-1447. Patnaik is affiliated with the UCMCNACO, LLC (ACO ID: A3531) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Patnaik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 36 traditional Medicare patients, billed 84 HCPCS/CPT codes, and received $9,380 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 462 prescription claims across 44 beneficiaries totaling $1,447,203 in drug costs, led by Xtandi (Enzalutamide). Open Payments data shows 15 records totaling $46,296. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $22,802 to $9,380. In contrast, Part D prescription costs have risen steadily, from $102,671 to $1,447,203. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$42K2016 Medicare payment: $22,802 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $41,606 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $35,277 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $28,777 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $26,775 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $23,867 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $19,557 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $12,298 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $9,380 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201651175$22,802
201780339$41,606
201890288$35,277
201974245$28,777
202054235$26,775
202155181$23,867
202266167$19,557
202345108$12,298
20243684$9,380

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$779K$1.6M2015 Drug cost: $102,671 (USD; Tot_Drug_Cst)2016 Drug cost: $224,422 (USD; Tot_Drug_Cst)2017 Drug cost: $463,725 (USD; Tot_Drug_Cst)2018 Drug cost: $1,513,826 (USD; Tot_Drug_Cst)2019 Drug cost: $1,558,035 (USD; Tot_Drug_Cst)2020 Drug cost: $988,757 (USD; Tot_Drug_Cst)2021 Drug cost: $1,043,056 (USD; Tot_Drug_Cst)2022 Drug cost: $1,547,861 (USD; Tot_Drug_Cst)2023 Drug cost: $1,214,668 (USD; Tot_Drug_Cst)2024 Drug cost: $1,447,203 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R71$102,671
20161244$224,422
201715102$463,725
201830290$1,513,826
201936354$1,558,035
202024231$988,757
202128301$1,043,056
202240509$1,547,861
202340549$1,214,668
202444462$1,447,203

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2974$115

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide371,110$504,270
ErleadaApalutamide19570$316,835
LynparzaOlaparib12360$203,677
OrgovyxRelugolix792,355$201,545
Abiraterone AcetateAbiraterone Acetate1464,425$134,237

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$2,836Janssen Global Services, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.3$43,460AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Akash Patnaik?

Tedicare shows public-source Medicare data for Akash Patnaik (NPI 1750360962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akash Patnaik have ACO affiliation data?

Akash Patnaik is shown with ACO affiliation data for UCMCNACO, LLC (MSSP, ACO ID A3531) and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Akash Patnaik?

Akash Patnaik is linked to THE UNIVERSITY OF CHICAGO MEDICAL CENTER (billing NPI 1033218128) in the available physician profile data.

Does Akash Patnaik have Open Payments data?

Akash Patnaik has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.